Phesgo instructions

Author: gnec

August undefined, 2024

WebPHESGO has different dosage and administration instructions than intravenous pertuzumab, intravenous trastuzumab, and subcutaneous trastuzumab when administered alone. Do not substitute PHESGO for or with pertuzumab, trastuzumab, ado-trastuzumab emtansine, or fam-trastuzumab deruxtecan. PHESGO must always be administered by a healthcare ... WebThe initial dose of Phesgo is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks by a dose of 600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units hyaluronidase administered subcutaneously over approximately 5 minutes.

Phesgo: Package Insert / Prescribing Information - Drugs.com

WebPHESGO has different dosage and administration instructions than intravenous pertuzumab, intravenous trastuzumab, and subcutaneous trastuzumab when administered alone. Do … team chat programs

Getting the PHESGO injection

WebJun 29, 2024 · The recommended initial dose of PHESGO is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks ... WebMar 2, 2024 · Phesgo is a cancer medicine for treating adults with ‘HER2-positive’ breast cancer (where a protein called HER2 is found on the cancer cells). It is used in combination with other cancer medicines in: patients with early breast cancer (when the cancer has not spread to other parts of the body) at high risk of coming back, after they have surgery; WebMar 16, 2024 · Phesgo 600 mg/600 mg, 1200 mg/600 mg solution for injection Package leaflet: Information for the user 1. What Phesgo is and what it is used for 2. What you need to know before you are given Phesgo 3. How you are given Phesgo 4. Possible side effects 5. How to store Phesgo 6. Contents of the pack and other information team chat restore

Phesgo ( pertuzumab / trastuzumab - European Medicines …

WebThe most common way of having trastuzumab and pertuzumab together is as a combination of the 2 drugs called Phesgo®. You have this as an injection under the skin (subcutaneous) every 3 weeks. This is a much quicker and easier way of having these drugs than into a vein (intravenously). Web− Phesgo has different dosage and administration instructions than intravenous pertuzumab, intravenous trastuzumab, and subcutaneous trastuzumab when administered alone. − Refer to the package insert for timing and … team chat rulesWebPhesgo should only be initiated under the supervision of a physician experienced in the administration of anti-cancer agents. Phesgo should be administered by a healthcare … southwest georgia periodontics albany ga

"WebMay 2, 2024 · Phesgo has different dosage and administration instructions than intravenous pertuzumab, intravenous trastuzumab, and subcutaneous trastuzumab when administered alone. Refer to the package insert for timing and sequence of … " - Phesgo instructions

Phesgo instructions

WebFollowing completion of Phesgo, continue to monitor for cardiomyopathy and assess LVEF every 6 months for at least 2 years as a component of adjuvant therapy MBC Pretreatment LVEF: ≥50% Monitor... WebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body …

Did you know?

WebOct 13, 2024 · When administered with PHESGO, the recommended initial dose of docetaxel is 75 mg/m 2 administered as an intravenous infusion. The dose may be escalated to 100 … WebMar 1, 2024 · PHESGO. PHESGO may harm the unborn baby. You should use effective contraception during treatment with PHESGO and for 7 months after stopping treatment. If you are a male patient taking PHESGO with a female partner who can become pregnant you should use effective contraception during treatment with PHESGO and for 7 months after …

WebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body … WebPhesgo’s initial loading dose is administered over approximately 8 minutes compared to 150 minutes for sequential infusion of loading doses for IV Perjeta and Herceptin. …

WebDec 18, 2024 · Phesgo, and market it in 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase per 15 mL injection in a single-dose vial and 600 mg pertuzumab, 600 ... Instructions for completing the form can be found at FDA.gov. 5 . REPORTING REQUIREMENTS . WebPHESGO for anaphylaxis, angioedema, interstitial pneumonitis, or acute respiratory distress syndrome. Monitor patients until symptoms completely resolve [see Warnings and …

WebBased on test results, your doctor may hold or discontinue treatment with PHESGO Contact a healthcare professional immediately for any of the following: new onset or worsening shortness of breath, cough, swelling of the ankles/legs, swelling of the face, palpitations, weight gain of more than 5 pounds in 24 hours, dizziness or loss of consciousness

WebJul 5, 2024 · Phesgo can be administered more quickly. “One advantage of this treatment over conventional treatment is the initial administration time is 8 minutes. If well-tolerated, subsequent treatments can... southwest georgia credit bureauWebuse prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or … south west georgia collegeWebOct 13, 2024 · The median duration of treatment for PHESGO was 24 weeks (range: 0-42 weeks). Serious adverse reactions occurred in 16% of patients who received PHESGO. Serious adverse reactions in > 1% of patients included febrile neutropenia (4%), neutropenic sepsis (1%), and neutrophil count decreased (1%). team chat rustWebPhesgo can only be obtained with a prescription and treatment should be started under the supervision of a doctor who is experienced in using cancer medicines and in a hospital setting where resuscitation equipment is available. Phesgo is given as an injection under the skin. The first dose is given over 8 minutes as an injection teamchat serverWebPHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). southwest georgia fitness center americus gaWebWhat does PHESGO treat? PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:. use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or … team chat roomWebBased on test results, your doctor may hold or discontinue treatment with PHESGO Contact a healthcare professional immediately for any of the following: new onset or worsening shortness of breath, cough, swelling of the ankles/legs, swelling of the face, palpitations, weight gain of more than 5 pounds in 24 hours, dizziness or loss of consciousness team chats app